HCA Healthcare, Inc. (NYSE:HCA) Position Increased by Fmr LLC

Fmr LLC raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 322.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,141,769 shares of the company’s stock after buying an additional 2,397,883 shares during the period. Fmr LLC owned about 1.24% of HCA Healthcare worth $1,276,909,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the business. Dai ichi Life Insurance Company Ltd boosted its holdings in HCA Healthcare by 12.6% during the third quarter. Dai ichi Life Insurance Company Ltd now owns 30,377 shares of the company’s stock worth $12,346,000 after buying an additional 3,407 shares in the last quarter. Private Trust Co. NA boosted its stake in HCA Healthcare by 16.4% in the 3rd quarter. Private Trust Co. NA now owns 1,137 shares of the company’s stock worth $462,000 after purchasing an additional 160 shares during the period. Hancock Whitney Corp boosted its stake in HCA Healthcare by 5.2% in the 3rd quarter. Hancock Whitney Corp now owns 4,111 shares of the company’s stock worth $1,671,000 after purchasing an additional 205 shares during the period. Independent Advisor Alliance boosted its stake in HCA Healthcare by 20.5% in the 3rd quarter. Independent Advisor Alliance now owns 1,142 shares of the company’s stock worth $464,000 after purchasing an additional 194 shares during the period. Finally, Harvest Fund Management Co. Ltd boosted its stake in HCA Healthcare by 3.1% in the 3rd quarter. Harvest Fund Management Co. Ltd now owns 1,778 shares of the company’s stock worth $723,000 after purchasing an additional 53 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Insider Activity

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the business’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the transaction, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,155 shares of company stock worth $5,608,990. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on HCA. Oppenheimer raised their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Truist Financial lifted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their target price for the company from $400.00 to $320.00 in a research note on Monday. Finally, KeyCorp cut their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $380.29.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $328.95 on Wednesday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The firm’s 50-day simple moving average is $376.47 and its 200-day simple moving average is $358.74. HCA Healthcare, Inc. has a twelve month low of $245.84 and a twelve month high of $417.14. The firm has a market cap of $83.32 billion, a P/E ratio of 14.77, a price-to-earnings-growth ratio of 1.25 and a beta of 1.68.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.80%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.